Fundz

RF Acquisition Corp II to merge with Nanyang Biologics

PUBLIC · RFAINov 06, 2025

Acquiring Company

RF Acquisition II

Acquired Company

Nanyang Biologics Pte. Ltd

United StatesSingaporeSoftwareArtificial IntelligenceBiotechnologyArtificial IntelligenceMachine Learning

Description

On October 2, 2025, RF Acquisition Corp II entered into a Business Combination Agreement with Nanyang Biologics Pte. Ltd., resulting in Nanyang becoming a wholly-owned subsidiary of PubCo. This merger aims to strengthen RF Acquisition's position in the deep technology sector. The agreement outlines a comprehensive amalgamation process. The completion of the Business Combination is critical for the company's operational future.

Quick answer

RF Acquisition II is acquiring Nanyang Biologics Pte. Ltd, announced November 6, 2025. RF Acquisition II is based in United States.

How much did RF Acquisition II pay for Nanyang Biologics Pte. Ltd?
The deal value was not disclosed.
What does RF Acquisition II do?
RF Acquisition Corp II is a Cayman Islands-based special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies across various industries.
Where are RF Acquisition II and Nanyang Biologics Pte. Ltd based?
RF Acquisition II is based in United States. Nanyang Biologics Pte. Ltd is based in Singapore.

Source: Fundz verified event record.

Other recent acquisitions in Software and Artificial Intelligence

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at RF Acquisition II, and when

When RF Acquisition II changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day RF Acquisition II raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RF Acquisition II, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RF Acquisition II. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RF Acquisition II

Location

United States

About

RF Acquisition Corp II is a Cayman Islands-based special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies across various industries. The company primarily aims to provide a platform for innovative firms seeking access to public markets. Its key products include units comprising one ordinary share and one right, as well as ordinary shares that have been registered for trading on The Nasdaq Stock Market. With a global focus, RF Acquisition Corp II has established its principal executive offices in Singapore, indicating its strategic outreach in Asian markets. As a relatively new entity, the company aims to leverage its corporate structure to enhance shareholder value through disciplined acquisition strategies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RF Acquisition II makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for RF Acquisition II's next move

Learn about Strategic plan

Frequently asked

Who acquired Nanyang Biologics Pte. Ltd?

Nanyang Biologics Pte. Ltd was acquired by RF Acquisition II, based in United States. The deal was reported on November 6, 2025. RF Acquisition Corp II is a Cayman Islands-based special purpose acquisition company (SPAC) focused on identifying and merging with high-growth companies across various industries. RF Acquisition II is publicly traded (RFAI) and operates in Software.

When did RF Acquisition II acquire Nanyang Biologics Pte. Ltd?

RF Acquisition II's acquisition of Nanyang Biologics Pte. Ltd was reported on November 6, 2025. On October 2, 2025, RF Acquisition Corp II entered into a Business Combination Agreement with Nanyang Biologics Pte. Ltd., resulting in Nanyang becoming a wholly-owned subsidiary of PubCo. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Nanyang Biologics Pte. Ltd do?

Nanyang Biologics Pte. Ltd. is an AI-driven drug discovery and biotechnology company known for its Vecura™ AI platform. The company focuses on developing innovative drug candidates by leveraging artificial intelligence and extensive research. It is privately held, operating in Biotechnology, and is based in Singapore.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.